Cardlytics Stock Options Expiring on 17th of January

CDLX Stock  USD 3.50  0.10  2.94%   

Cardlytics Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Cardlytics Total Stockholder Equity

Total Stockholder Equity

98 Million

At this time, Cardlytics' Total Stockholder Equity is fairly stable compared to the past year.

Cardlytics Corporate Management

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.